Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Harbor Venture Partners is a healthcare and life science-focused placement agent and investment banking firm rather than a drug-development biotech company. The firm specializes in raising capital for venture-backed and private-equity backed healthcare and life science companies from the global institutional investment community. Its business centers on private placements and related fundraising advisory work, with a trans-Atlantic footprint spanning the United States and Switzerland. New Harbor Venture Partners has highlighted transactions involving medtech and healthcare companies such as Ivenix, Augmedics, and MacuLogix. For biotech analysts, the key point is that NHVP is an intermediary and capital-raising advisor serving the sector, not a therapeutics developer with an internal R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Harbor Venture Partners.